Press Releases

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

Blue Earth Diagnostics announced that the FDA has accepted its filing for a New Drug Application for 18F-rhPSMA-7.3, an investigational radiohybrid Prostate-Specific Membrane Antigen-targeted (PSMA) PET imaging agent. The submission is for the use of 18F-rhPSMA-7.3 PET for diagnostic imaging of prostate cancer.

CD BioGlyco Supports Glycan Separation and Purification with Advanced Techniques

Profacgen Enhanced Its Structure-based Virtual Screening (SBVS) Service Recently

Creative Biostructure Uncovers Insights for Pathology Research with Advanced iEM Platform

Alfa Chemistry Newly Releases Biological Stains for Laboratory and Diagnostic Use

BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS

BioIVT Acquires Fidelis Research

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Zebrafish Disease Models: Accelerating Human Disease Studies and Biomedical Research

Microbiosci Offers Real-time PCR Kits to Support Research Applications in Viral Detection

CRISPR/Cas9 Platform Provides Accurate Gene Knockout Mouse Models for Immunology Research and Drug Discovery

Creative Bioarray Provides Cell Patterning Customization and Detection Services for Drug Screening

Creative Enzymes Offers Products to Support the Clinical and Research Use of Liver Function Evaluation

Creative Proteomics Cytokine Accelerates Your Project with Its Colony Stimulating Factor Detection Service

Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals

Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins

Quinten Health closes its financing round to advance disease modeling platforms and virtual twins in real-world

QUINTEN HEALTH has announced that it has closed its financing round to advance disease modeling platforms and virtual twins in real-world.

The Harley Street Medical Area (HSMA) Healthcare Conference unites world-leading institutions to discuss the future of life science innovation in London

Harley Street Medical Area has announced its Healthcare Conference is taking place on Wednesday 19th October 2022.

DAMAN enters ambitious European precision medicine healthcare project

Daman Digital (DAMAN), a digital healthcare partner based in Denmark, has announced its part in the ambitious European precision medicine healthcare project, SQUEEZE.

BioIVT Launches GMP-grade VivoSTART Leukopaks for Cell and Gene Therapy Manufacturing

VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development.

VERICHEM OFFERS CLINICAL REFERENCE MATERIALS FOR THE CALIBRATION VERIFICATION TESTING OF LACTATE ASSAYS

VERICHEM LABORATORIES now offers a liquid stable and ready-to-use set of clinical reference materials for use with the clinical testing of Lactate.